US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adia Nutrition, Inc.

0.1700

0.0000

Volume:- -

Turnover:- -

Market Cap:16.05M

PE:-40.24

High:0.1700

Open:0.1700

Low:0.1700

Close:0.1700

52wk High:0.2777

52wk Low:0.0177

Shares:94.40M

Float Shares:94.40M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0042

EPS(LYR):0.0000

ROE:-1460.81%

ROA:-36.13%

PB:-38.95

PE(LYR):-21,250.00

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Adia Nutrition says IRB clears four clinical studies of AdiaVita therapies

Adia Nutrition wins IRB approval for chronic kidney disease stem cell trial

Adia Nutrition to rebrand as Adia Med in regenerative medicine shift

Adia Nutrition partners with Atlanta clinic to supply products for 100-patient autism study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADIA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","market":"US","secType":"STK","nameCN":"Adia Nutrition, Inc.","latestPrice":0.17,"timestamp":1778769060000,"preClose":0.17,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":94404700,"shares":94404700,"eps":-0.004225,"marketStatus":"Trading","change":0,"latestTime":"05-14 10:31:00 EDT Delay","open":0.17,"high":0.17,"low":0.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.004225,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778788800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIA\",,,,,undefined,":{"symbol":"ADIA","floatShares":94404700,"roa":"-36.13%","roe":"-1460.81%","lyrEps":-0.000008,"shares":94404700,"dividePrice":0,"high":0.17,"amplitude":0,"preClose":0.17,"low":0.17,"week52Low":0.0177,"pbRate":"-38.95","psRate":"22.91","week52High":0.27767,"institutionHeld":0,"latestPrice":0.17,"eps":-0.004225,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.004225,"open":0.17,"prevYearClose":0.078,"prevWeekClose":0.16,"prevMonthClose":0.1848,"prevQuarterClose":0.1,"fiveDayClose":0.17,"twentyDayClose":0.14,"sixtyDayClose":0.2089},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADIA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634628051","title":"Adia Nutrition says IRB clears four clinical studies of AdiaVita therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2634628051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634628051?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:22","pubTimestamp":1778509346,"startTime":"0","endTime":"0","summary":"Adia Nutrition secured IRB clearance for four human studies of AdiaVita stem cell and exosome therapies.Flagship chronic kidney disease study was registered on ClinicalTrials.gov, with recruitment set to start this week.Winter Park autism study completed recruitment, with treatment underway; Georgia autism study and lower back pain study remain in final registration stages.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL14vHt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633949587","title":"Adia Nutrition wins IRB approval for chronic kidney disease stem cell trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633949587","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633949587?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:21","pubTimestamp":1777990889,"startTime":"0","endTime":"0","summary":"Adia Nutrition secured IRB clearance for its chronic kidney disease stem cell study, clearing the trial to move into recruitment.Study was submitted to ClinicalTrials.gov, targeting adults with Stage 2-4 CKD to evaluate safety and track kidney function and inflammation markers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief on May 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLb7bJt9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284416","title":"Adia Nutrition to rebrand as Adia Med in regenerative medicine shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284416","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284416?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:31","pubTimestamp":1776256312,"startTime":"0","endTime":"0","summary":"Adia Nutrition began process to change corporate name to Adia Med to align branding with its regenerative medicine, stem cell therapy, and biologics strategy.Operations are now organized around Adia Med clinics focused on advanced treatments, alongside Adia Labs developing and selling biologic products.Rebranding ties to shift toward IRB-approved clinical studies aimed at supporting insurance reimbursement pathways.Adia expects name change to be completed in coming months, pending customary regulatory filings.Ticker symbol ADIA is expected to remain unchanged during transition.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3Bf17M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949477","title":"Adia Nutrition partners with Atlanta clinic to supply products for 100-patient autism study","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949477","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949477?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:32","pubTimestamp":1775651558,"startTime":"0","endTime":"0","summary":"Adia Nutrition entered strategic partnership with an Atlanta clinic to supply regenerative products for a new Autism Spectrum Disorder clinical study.Adia Labs will act as exclusive supplier for study, supporting Adia Nutrition’s 2026 push to generate clinical evidence for regenerative therapies.Study will test AdiaVita, an umbilical cord blood-derived product, in 100 participants receiving three infusions each, totaling 300 infusions.Single AdiaVita infusion at Adia Med of Winter Park typically costs USD 8,000.Adia Med of Winter Park plans to start its own autism study in May 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL6lyNK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ADIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ADIA\",params:#limit:6,delay:false,,,undefined,":[]}}